BR0313589A - Use of fermented wheat germ extract as anti-inflammatory agent - Google Patents
Use of fermented wheat germ extract as anti-inflammatory agentInfo
- Publication number
- BR0313589A BR0313589A BR0313589-6A BR0313589A BR0313589A BR 0313589 A BR0313589 A BR 0313589A BR 0313589 A BR0313589 A BR 0313589A BR 0313589 A BR0313589 A BR 0313589A
- Authority
- BR
- Brazil
- Prior art keywords
- wheat germ
- inflammatory agent
- germ extract
- fermented wheat
- avemar
- Prior art date
Links
- 241000209140 Triticum Species 0.000 title abstract 3
- 235000021307 Triticum Nutrition 0.000 title abstract 3
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 3
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 3
- 239000000284 extract Substances 0.000 title abstract 3
- 239000010205 Avemar Substances 0.000 abstract 2
- 206010003246 arthritis Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"USO DE EXTRATO DE GERME DE TRIGO FERMENTADO COMO AGENTE ANTIINFLAMATóRIO". A presente invenção refere-se a um uso terapêutico de um extrato de germe de trigo fermentado sob a marca registrada Avemar<32>, mais especificamente ao uso de Avemar<32> para a fabricação de um medicamento útil como agente antiinflamatório para prevenção ou tratamento ou alívio de condições inflamatórias, particularmente artrite."USE OF FERMENTED WHEAT GERM EXTRACT AS ANTI-INFLAMMATORY AGENT". The present invention relates to a therapeutic use of a fermented wheat germ extract under the trademark Avemar <32>, more specifically to the use of Avemar <32> for the manufacture of a medicament useful as an anti-inflammatory agent for prevention or treatment. or relief from inflammatory conditions, particularly arthritis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0202638A HUP0202638A3 (en) | 2002-08-09 | 2002-08-09 | Use of fermented wheat-germ extract for preparation of antiphlogistic compositions |
| PCT/HU2003/000065 WO2004014406A1 (en) | 2002-08-09 | 2003-08-08 | Use of fermented wheat germ extract as anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0313589A true BR0313589A (en) | 2005-07-12 |
Family
ID=89980690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0313589-6A BR0313589A (en) | 2002-08-09 | 2003-08-08 | Use of fermented wheat germ extract as anti-inflammatory agent |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1536809A1 (en) |
| JP (1) | JP2006501214A (en) |
| KR (1) | KR20050059066A (en) |
| CN (1) | CN1674924A (en) |
| AU (1) | AU2003255854A1 (en) |
| BR (1) | BR0313589A (en) |
| CA (1) | CA2494744A1 (en) |
| EA (1) | EA007844B1 (en) |
| HR (1) | HRP20050114A2 (en) |
| HU (1) | HUP0202638A3 (en) |
| IL (1) | IL166732A0 (en) |
| MX (1) | MXPA05001469A (en) |
| NO (1) | NO20051168L (en) |
| PL (1) | PL375391A1 (en) |
| WO (1) | WO2004014406A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2908998A1 (en) * | 2006-11-24 | 2008-05-30 | Bao Quoc Ho | Use of enzyme concentrate from cereal germ for therapeutic purposes to manufacture an anti inflammatory drug to treat arthritis and osteoarthritis |
| HUP0900614A2 (en) | 2009-09-29 | 2011-05-30 | Mate Dr Hidvegi | Preparation comprising dehydrated, fermented material with amorphous crystaline structure and process for its production |
| US9480725B2 (en) | 2009-05-20 | 2016-11-01 | The Regents Of The University Of California | Fermented wheat germ proteins (FWGP) for the treatment of cancer |
| US20120164132A1 (en) * | 2010-08-02 | 2012-06-28 | Mate Hidvegi | Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses |
| GB201108560D0 (en) | 2011-05-20 | 2011-07-06 | 3 Ch Ltd | Use of fermented wheat germ in the treatment of inflammatory bowel disease |
| GB201110746D0 (en) | 2011-06-23 | 2011-08-10 | Biropharma Uk Ltd | Wheat germ derived material |
| JP6115995B2 (en) * | 2013-04-24 | 2017-04-19 | 株式会社日清製粉グループ本社 | Non-enzymatic saccharification reaction inhibitor |
| CN104381450A (en) * | 2014-10-15 | 2015-03-04 | 张士远 | Health milk for treatment of gastric mucosal injury and preparation method thereof |
| WO2017196048A1 (en) * | 2016-05-11 | 2017-11-16 | 씨제이제일제당 (주) | Externally applied composition for alleviating skin wrinkles, containing extract of fermented wheat germ product as active ingredient |
| KR101955111B1 (en) * | 2016-09-23 | 2019-03-07 | 씨제이제일제당 (주) | External composition for soothing effect on the skin comprising an extract of fermented wheat germ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07242537A (en) * | 1994-03-04 | 1995-09-19 | Kibun Foods Inc | Production of substance having anti-inflammatory activity and anti-inflammatory agent |
| JPH08337536A (en) * | 1995-06-14 | 1996-12-24 | Asahi Breweries Ltd | Agent for antiactive oxygen, antiactive oxygen agent, cosmetic, food and medicine containing the same as active ingredient |
| HU223344B1 (en) * | 1997-08-13 | 2004-06-28 | Máté Hidvégi | Immunostimulant and metastasis-inhibiting fermented dried material, pharmaceutical compositions containing same, process for its production and its uses |
-
2002
- 2002-08-09 HU HU0202638A patent/HUP0202638A3/en unknown
-
2003
- 2003-08-08 BR BR0313589-6A patent/BR0313589A/en not_active Application Discontinuation
- 2003-08-08 EP EP03784303A patent/EP1536809A1/en not_active Withdrawn
- 2003-08-08 KR KR1020057002283A patent/KR20050059066A/en not_active Application Discontinuation
- 2003-08-08 CN CNA038189003A patent/CN1674924A/en active Pending
- 2003-08-08 PL PL03375391A patent/PL375391A1/en not_active Application Discontinuation
- 2003-08-08 MX MXPA05001469A patent/MXPA05001469A/en unknown
- 2003-08-08 AU AU2003255854A patent/AU2003255854A1/en not_active Abandoned
- 2003-08-08 WO PCT/HU2003/000065 patent/WO2004014406A1/en not_active Application Discontinuation
- 2003-08-08 JP JP2004527076A patent/JP2006501214A/en active Pending
- 2003-08-08 EA EA200500326A patent/EA007844B1/en not_active IP Right Cessation
- 2003-08-08 CA CA002494744A patent/CA2494744A1/en not_active Abandoned
-
2005
- 2005-02-03 HR HR20050114A patent/HRP20050114A2/en not_active Application Discontinuation
- 2005-02-07 IL IL16673205A patent/IL166732A0/en unknown
- 2005-03-04 NO NO20051168A patent/NO20051168L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA007844B1 (en) | 2007-02-27 |
| HUP0202638A2 (en) | 2004-06-28 |
| JP2006501214A (en) | 2006-01-12 |
| HUP0202638A3 (en) | 2007-08-28 |
| AU2003255854A1 (en) | 2004-02-25 |
| CA2494744A1 (en) | 2004-02-19 |
| EP1536809A1 (en) | 2005-06-08 |
| IL166732A0 (en) | 2006-01-15 |
| PL375391A1 (en) | 2005-11-28 |
| MXPA05001469A (en) | 2005-06-06 |
| HU0202638D0 (en) | 2002-10-28 |
| CN1674924A (en) | 2005-09-28 |
| NO20051168L (en) | 2005-03-04 |
| KR20050059066A (en) | 2005-06-17 |
| HRP20050114A2 (en) | 2005-10-31 |
| WO2004014406A1 (en) | 2004-02-19 |
| EA200500326A1 (en) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
| MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
| MXPA05011208A (en) | Topical formulation of ivermectin for the treatment of dermatological conditions. | |
| NO20042596L (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| IL154888A (en) | Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis | |
| WO2009109618A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 | |
| IL172773A (en) | Formulations for the treatment of arthritis conditions | |
| TW200719882A (en) | Treatment of connective tissue diseases of the skin | |
| ATE384058T1 (en) | THIAZOLE DERIVATIVES | |
| WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
| NO20051168L (en) | Use of fermented wheat germ extract as anti-inflammatory agent | |
| TW200510367A (en) | Novel lapachone compounds, their preparation, and the use thereof | |
| CR6824A (en) | ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS | |
| PT1492773E (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| WO2006002846A3 (en) | New analogs of nitrobenzylthioinosine | |
| PE20030236A1 (en) | DERIVATIVES OF BENZIMIDAZOLE 1-ARIL-2-N, S- OR O-SUBSTITUTES, OBTAINING DRUGS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES | |
| CY1106129T1 (en) | KITALOPRAM FOR THE TREATMENT OF HIGH BLOOD PRESSURE | |
| WO2004108094A3 (en) | Sulfonamide-substituted chalcone derivatives and their use to treat diseases | |
| TNSN06068A1 (en) | Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application | |
| PL1700597T3 (en) | Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application | |
| CY1110563T1 (en) | Derivative of isoxazolic acid for the relief of neuropathic pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 36/899 (2006.01), A61P 29/00 (2006.01), A61P |